SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

NCT06859775 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent or Metastatic Cervical Cancer

Interventions

DRUG: SHR-A1811
DRUG: Adebelimab injection
DRUG: Bevacizumab injection
DRUG: SHR-8068
DRUG: Cisplatin injection
DRUG: Carboplatin injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.